North America

VC-backed Personalis unveils IPO

Personalis Inc, a provider of advanced genomics solutions for cancer, has debuted its IPO after pricing its nearly 8 million shares at $17 per share. The stock began trading June 20, 2019 on the NASDAQ under the ticker symbol "PSNL." Morgan Stanley, BofA Merrill Lynch and Cowen are the lead underwriters. Personalis' pre-IPO backers included Lightspeed Venture Partners, Abingworth and Mohr Davidow Ventures.

Comet Therapeutics picks up $28.5 mln Series A

Comet Therapeutics, a biotech firm, has raised $28.5 million in Series A funding. Canaan and Sofinnova Partners led the round.

Partech leads Series B round for Bitrise

Bitrise, a mobile continuous integration and delivery platform, has secured $20 million in Series B funding. Partech led the round with participation from Zobito, OpenOcean, Y Combinator and Fiedler Capital. Partech’s Reza Malekzadeh and OpenOcean’s Ekaterina Almasque will join the company’s board.

Rhumbix procures $14.3 mln Series B

San Francisco-based Rhumbix, a mobile platform for smarter construction sites, has secured $14.3 million in Series B funding. Blackhorn Ventures and Tenfore Holdings led the round with participation from Greylock Partners, S28 Capital, South Park Ventures and Glynn Capital.

Chinese B2B auto parts trading platform Haoqipei inks $60 mln

China-based Haoqipei, a B2B auto parts trading platform, has secured $60 million in Series D funding. Access Technology Ventures led the round with participation from other investors that included XVC Venture Capital, Jeneration Capital, DCM and SIG.

Dawn Capital collects $125 mln for fourth fund: Reuters

Dawn Capital, an early-stage venture firm, has raised $125 million for its fourth fund, according to Reuters. The Dawn Capital Opportunities Fund targets European B2B tech companies.

Ockam nets $3.2 mln seed

Ockam, a severless platform for IoT developers, has raised $3.2 million in seed funding, according to a blog post on its site. The investors were Core Ventures, Future Ventures, Okta and SGH Capital.

Engage3 pockets $12 mln Series C

Engage3, which helps retailers manage their price image through accurate competitive data, data science and AI-powered software solutions, has raised $12 million in Series C financing. The March Fund led the round.

Axial Biotherapeutics scores $10 mln

Axial Biotherapeutics, a developer of gut-targeted therapeutics for neurodegenerative diseases and neurodevelopmental disorders, has secured $10 million in funding. The backer was Taiho Ventures LLC.

Druva racks up $130 mln

Sunnyvale, California-based Druva Inc, a provider of cloud data protection and management solutions, has secured $130 million in funding. Viking Global Investors led the round.